# New Horizon Aircraft Ltd.: financial statements, quarterly

HOVR · Nasdaq · CIK 1930021 · [Industrials](/sectors/industrials.md) · fiscal year ends May 31

Pages: [Overview](/companies/hovr.md) · [Financials](/companies/hovr/financials.md) · [Filings](/companies/hovr/filings.md) · [Insiders](/companies/hovr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hovr/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2022-06-30) | period not labelled (2022-08-31) | period not labelled (2022-09-30) | period not labelled (2022-11-30) | period not labelled (2023-02-28) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | period not labelled (2023-08-31) | Q3 FY2023 (2023-09-30) | period not labelled (2023-11-30) | Q4 FY2023 (2023-12-31) | Q3 FY2024 (2024-02-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $bn | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-24-034689.md) | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-24-034689.md) |
| Operating income | $bn | [(0.0)](/filings/0001493152-23-027611.md) | not reported | [(0.0)](/filings/0001213900-23-087663.md) | not reported | [(0.0)](/filings/0001213900-24-034689.md) | [(0.0)](/filings/0001493152-23-017275.md) | [(0.0)](/filings/0001493152-23-027611.md) | not reported | [(0.0)](/filings/0001213900-23-087663.md) | not reported | [(0.0) d](/filings/0001213900-24-027309.md) | [(0.0)](/filings/0001213900-24-034689.md) |
| Interest expense | $bn | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-24-034689.md) | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-24-034689.md) |
| Income tax | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-23-087663.md) | not reported | [0.0 d](/filings/0001213900-24-027309.md) | not reported |
| Net income | $bn | [(0.0)](/filings/0001493152-23-027611.md) | [(0.0)](/filings/0001213900-24-034689.md) | [(0.0)](/filings/0001213900-23-087663.md) | [(0.0)](/filings/0001213900-24-034689.md) | [(0.0)](/filings/0001213900-24-034689.md) | [499](/filings/0001213900-23-087663.md) | [0.0](/filings/0001493152-23-027611.md) | [(0.0)](/filings/0001213900-24-034689.md) | [0.0](/filings/0001213900-23-087663.md) | [(0.0)](/filings/0001213900-24-034689.md) | [0.0 d](/filings/0001213900-24-027309.md) | [(0.0)](/filings/0001213900-24-034689.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.04)](/filings/0001213900-24-034689.md) | not reported | not reported | not reported | not reported | not reported | not reported | [(0.45)](/filings/0001213900-24-034689.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [(0.04)](/filings/0001213900-24-034689.md) | not reported | not reported | not reported | not reported | not reported | not reported | [(0.45)](/filings/0001213900-24-034689.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2022-11-30) | FY2023 (2022-12-31) | period not labelled (2023-02-28) | Q1 FY2023 (2023-03-31) | period not labelled (2023-05-31) | Q2 FY2023 (2023-06-30) | period not labelled (2023-08-31) | Q3 FY2023 (2023-09-30) | period not labelled (2023-11-30) | FY2023 (2023-12-31) | Q3 FY2024 (2024-02-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [0.1](/filings/0001213900-24-027309.md) | not reported | [0.5](/filings/0001493152-23-017275.md) | [0.2](/filings/0001213900-24-034689.md) | [0.3](/filings/0001493152-23-027611.md) | not reported | [0.1](/filings/0001213900-23-087663.md) | not reported | [0.0](/filings/0001213900-24-027309.md) | [4.4](/filings/0001213900-24-034689.md) |
| Current assets | $m | not reported | not reported | [0.1](/filings/0001213900-24-027309.md) | not reported | [0.8](/filings/0001493152-23-017275.md) | [0.2](/filings/0001213900-24-034689.md) | [0.5](/filings/0001493152-23-027611.md) | not reported | [0.2](/filings/0001213900-23-087663.md) | not reported | [0.1](/filings/0001213900-24-027309.md) | [6.6](/filings/0001213900-24-034689.md) |
| Total assets | $m | not reported | not reported | [0.5](/filings/0001213900-24-027309.md) | not reported | [119](/filings/0001493152-23-017275.md) | [0.4](/filings/0001213900-24-034689.md) | [120](/filings/0001493152-23-027611.md) | not reported | [122](/filings/0001213900-23-087663.md) | not reported | [122](/filings/0001213900-24-027309.md) | [6.8](/filings/0001213900-24-034689.md) |
| Current liabilities | $m | not reported | not reported | [0.4](/filings/0001213900-24-027309.md) | not reported | [0.1](/filings/0001493152-23-017275.md) | [1.5](/filings/0001213900-24-034689.md) | [0.2](/filings/0001493152-23-027611.md) | not reported | [1.3](/filings/0001213900-23-087663.md) | not reported | [1.0](/filings/0001213900-24-027309.md) | [2.3](/filings/0001213900-24-034689.md) |
| Total liabilities | $m | not reported | not reported | [0.4](/filings/0001213900-24-027309.md) | not reported | [3.6](/filings/0001493152-23-017275.md) | [1.8](/filings/0001213900-24-034689.md) | [3.6](/filings/0001493152-23-027611.md) | not reported | [13.6](/filings/0001213900-23-087663.md) | not reported | [7.1](/filings/0001213900-24-027309.md) | [23.0](/filings/0001213900-24-034689.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-24-034689.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [0.0](/filings/0001213900-23-087663.md) | [(0.7)](/filings/0001213900-24-034689.md) | [0.0](/filings/0001213900-24-027309.md) | [(1.0)](/filings/0001213900-24-034689.md) | [(2.7)](/filings/0001213900-23-087663.md) | [(1.4)](/filings/0001213900-24-034689.md) | [(3.0)](/filings/0001213900-23-087663.md) | [(1.8)](/filings/0001213900-24-034689.md) | [(12.5)](/filings/0001213900-23-087663.md) | [(1.0)](/filings/0001213900-24-034689.md) | [(6.9)](/filings/0001213900-24-027309.md) | [(16.1)](/filings/0001213900-24-034689.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(314)](/filings/0001493152-23-017275.md) | [(239) d](/filings/0001493152-23-027611.md) | [(215) d](/filings/0001213900-23-087663.md) | [(1,357) d](/filings/0001213900-24-027309.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2023-02-28) | period not labelled (2023-08-31) | period not labelled (2023-11-30) | Q3 FY2024 (2024-02-29) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.3](/filings/0001213900-24-034689.md) | [5.1](/filings/0001213900-24-086732.md) | [5.1](/filings/0001213900-25-003183.md) | [11.7](/filings/0001213900-25-031284.md) | [19.2](/filings/0001213900-25-097933.md) | [24.6](/filings/0001213900-26-004152.md) | [29.5](/filings/0001213900-26-043197.md) | [37.1](/filings/0001213900-26-108211.md) | [42.1](/filings/0001213900-26-004152.md) | [44.3](/filings/0001213900-26-043197.md) | [65.6](/filings/0001213900-26-108211.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 67,123,941 at 2026-10-09, from the cover of the [10-Q filed 2026-10-09](/filings/0001213900-26-108211.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.